For generations, men have quietly endured the indignities of an aging body, mistaking suffering for inevitability. In Kisumu, Kenya, a 69-year-old man's two-year struggle with an enlarged prostate — marked by sleepless nights, social withdrawal, and lost confidence — has found resolution through a water vapor therapy that dissolves tissue without a scalpel, preserving both function and dignity. His story arrives at a moment when 94 million men worldwide carry this same burden, many of them in regions where advanced urological care has long felt out of reach. The quiet expansion of minimally in
Minimally invasive therapy offers new hope for men with enlarged prostate
Take charge of your health. Don't fear. Come to the doctor.
So J O lived with this for two years before trying anything new. What kept him from seeking help sooner?
Fear, mostly. He'd watched other men go through traditional prostate surgery and was convinced it would be dangerous. He was also worried about what it might do to his sexual function at 69.
That's understandable, but I want to be clear—the source doesn't say he delayed seeking help. He did see a doctor in 2022 and got medication. He just delayed moving to a more invasive treatment.
Right. So the medication worked for a while, but then what changed?
It helped him cope, but the symptoms were still disrupting his life—the sleep deprivation, the social isolation, the incontinence. After two years, he wanted something more lasting.
And that's when he found Rezūm through social media. I'm curious whether that's common—patients discovering treatments online rather than doctors recommending them.
The source doesn't tell us whether Dr. Mokua would have suggested it unprompted. But once J O brought it up, Mokua assessed him and confirmed he was suitable.
The procedure itself sounds almost anticlimactic. He said he didn't feel anything.
That's the whole point of minimally invasive. No external incision, no major trauma to the body. But Mokua is careful to say improvement takes time—weeks, sometimes months.
And on the sexual function question—Mokua says Rezūm is "designed to preserve" normal ejaculation in "many appropriately selected patients." That's careful language. It's not a guarantee.
No, it's not. Individual outcomes vary. That's why the conversation between patient and doctor matters so much.
What about access? Is this treatment available widely in Kenya?
The source suggests it's new to the region. Onsongo talks about bringing it "locally in Kisumu," which implies it wasn't there before. Equipment had to be transported from Nairobi for J O's procedure.
That's the real story underneath—not just that J O got relief, but that specialized care is starting to reach areas outside the capital.
The Pulse
- A man from Migori spent two years waking three times a night, eventually losing control of his bladder in public — a condition that quietly dismantled his social life and self-worth.
- Fear of conventional prostate surgery, and its known risks to sexual function, kept him from seeking a permanent solution for far longer than necessary.
- A chance discovery on social media led him to Rezūm Water Vapor Therapy — a procedure that uses injected steam to shrink prostate tissue from within, leaving no external wound and no general anesthesia.
- The treatment, now available at Aga Khan Hospital Kisumu, signals a shift: specialized urological care is beginning to reach Western Kenya without requiring patients to travel to Nairobi.
- Recovery is gradual — full results may take three months — but the patient is already urging other men not to normalize their symptoms or delay seeking help.
For generations, men have quietly endured the indignities of an aging body, mistaking suffering for inevitability. In Kisumu, Kenya, a 69-year-old man's two-year struggle with an enlarged prostate — marked by sleepless nights, social withdrawal, and lost confidence — has found resolution through a water vapor therapy that dissolves tissue without a scalpel, preserving both function and dignity. His story arrives at a moment when 94 million men worldwide carry this same burden, many of them in regions where advanced urological care has long felt out of reach. The quiet expansion of minimally invasive medicine into underserved communities is, in its own way, a form of justice.
J O spent nearly two years measuring his nights by bathroom visits. The 69-year-old from Migori Municipality would wake repeatedly, his bladder overriding his sleep, until what began as a minor inconvenience had become something that eroded his confidence and left him incontinent at unpredictable moments — sometimes while simply sitting in company. His diagnosis was benign prostatic hyperplasia, a non-cancerous prostate enlargement that obstructs urine flow and affects roughly 94 million men globally aged 40 and older. In Kenya, the number of affected men nearly doubled between 2000 and 2019.
Medication helped manage his symptoms for a time, but J O wanted something permanent. Conventional surgery frightened him — he had seen other patients undergo the standard transurethral resection procedure and feared he would not survive it. At 69, he was also still sexually active and worried about the procedure's known risk of affecting ejaculation. Then, through social media, he found Rezūm Water Vapor Therapy and contacted Dr. Winstar Mokua, a consultant urologist at Aga Khan Hospital Kisumu, who confirmed he was a suitable candidate.
The procedure itself was nothing like the surgery he had imagined. A small device is threaded through the urethra to deliver controlled bursts of water vapor into the enlarged prostate tissue. The treated cells break down and are absorbed by the body over time, shrinking the prostate and restoring urine flow — no incision, no general anesthesia. Unlike traditional surgery, Rezūm is designed to preserve normal ejaculation in appropriately selected patients, though outcomes vary and careful patient-doctor discussion remains essential. Improvement is gradual, with full benefit sometimes taking up to three months.
For Dr. Simon Onsongo, director of Aga Khan Hospital Kisumu, the arrival of this technology in the region matters beyond any single patient. Bringing specialized urological care to Western Kenya reduces the burden on men who would otherwise travel to Nairobi for treatment. For J O, now recovering with a catheter and looking toward ordinary freedoms — uninterrupted sleep, travel, social visits without anxiety — the message to other men is direct: frequent night-time urination, urgency, and leakage are not simply the price of growing older. "Take charge of your health," he says. "Don't fear. Come to the doctor."
J O spent nearly two years measuring his nights by bathroom visits. The 69-year-old from Migori Municipality would wake three times some nights, his bladder demanding attention when he most needed sleep. What began as a minor inconvenience in 2022 had become something far more disruptive—a condition that eroded his confidence, fractured his social life, and left him incontinent at unpredictable moments. "It used to come even when you are sitting somewhere," he recalls. "Sometimes you can still wet your trousers."
His doctor diagnosed benign prostatic hyperplasia, or BPH—a non-cancerous enlargement of the prostate gland that presses against the urethra and obstructs urine flow. The condition is far from rare. A Global Burden of Disease analysis found that roughly 94 million men aged 40 and older worldwide were living with BPH in 2019, nearly double the 51.1 million recorded two decades earlier. In Kenya alone, the numbers climbed from about 64,600 men in 2000 to 126,000 by 2019. For two years, medication had helped J O manage the symptoms, but he wanted something more permanent. The prospect of conventional surgery terrified him. He had watched other patients undergo transurethral resection of the prostate—the standard procedure—and the experience left him convinced he would not survive the operation. At 69, he remained sexually active, and he feared that surgery might damage his ability to ejaculate normally.
Then, through social media, J O discovered Rezūm Water Vapor Therapy, a minimally invasive alternative that was beginning to reach Kenya. He contacted Dr. Winstar Mokua, a consultant urologist at Aga Khan Hospital Kisumu, who assessed him and confirmed he was a suitable candidate. The procedure was initially scheduled for August 21 but was delayed while equipment was transported from Nairobi. When J O finally entered the procedure room, the experience bore no resemblance to the surgery he had feared. "After that, I didn't feel it," he says. The entire process was painless.
Rezūm works by threading a small delivery device through the urethra to reach the enlarged prostate tissue. Controlled doses of water vapor are then injected into targeted areas, damaging selected cells. The body gradually breaks down and absorbs the treated tissue, shrinking the prostate and creating more space for urine to flow. Unlike traditional surgery, there is no external incision. Dr. Mokua emphasizes that improvement is not immediate—patients may begin noticing changes around two weeks, with full benefit sometimes taking up to three months. J O currently has a catheter in place and is in the early stages of recovery.
The sexual function question that had weighed on J O's mind carries real weight in treatment decisions. Traditional TURP can affect ejaculation, sometimes causing semen to travel backward into the bladder rather than forward. Rezūm is designed to preserve normal ejaculation in many appropriately selected patients, though individual outcomes vary. Dr. Mokua stresses that treatment decisions must follow careful conversations between patients and doctors about expected benefits, risks, and alternatives. Not every man with an enlarged prostate needs surgery. Treatment often begins with medication and monitoring, with intervention reserved for cases where symptoms remain severe despite medication or when complications develop—urinary retention, recurrent infections, bladder stones, bleeding, or kidney damage.
Dr. Simon Onsongo, director of Aga Khan Hospital Kisumu, sees the arrival of minimally invasive prostate treatment as significant for the region. "If we can get them locally in Kisumu and in this part of the world, that is a plus for us," he says. Bringing specialized urological care to Western Kenya could reduce the need for patients to travel to Nairobi or beyond for treatment. For J O, the journey has been about reclaiming ordinary freedoms—sleeping through the night, traveling, visiting friends without constantly calculating the distance to the nearest toilet. His family pushed him toward a permanent solution, and his personal medical insurance ultimately covered the cost. Now recovering at the hospital, he carries a simple message for other men: do not dismiss frequent night-time urination, urgency, weak urine flow, or leakage as merely part of aging. "Take charge of your health," he says. "It is very, very important to take charge of your health. Don't fear. Come to the doctor."
Notable Quotes
When I saw the way the operation was done for other people in this ward, I felt like I was going to die.— J O, describing his fear of conventional prostate surgery
BPH is a benign condition. Prostate cancer is a separate disease that requires its own assessment.— Dr. Winstar Mokua, consultant urologist